💊 Medicine AT September 8, 2026

Bezalip retard 400 mg - Filmtabletten 400 mg (Retardtablette)

📷 Wikipedia: Bezafibrate · Source

ATC: C10AB02
Reason: Verzögerung bei der Herstellung
Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland
Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-07]

⚠️

Shortage ongoing

BEZAFIBRAT is currently in short supply in AT.

📈 Timeline

2 days active so far

September 9, 2026 September 10, 2026

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

BEZAFIBRAT

Agency-published detail

🚫 Parallel export ban active · ATC: C10AB02 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-07]

First published

September 8, 2026

Last refreshed by us

14 hours ago

Severity (as classified)

High

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 9, 2026

Agency-reported start

September 8, 2026

Days active

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Bezalip retard 400 mg - Filmtabletten 400 mg (Retardtablette). 🚫 Parallel export ban active · ATC: C10AB02 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Actavis Group PTC ehf., Dalshraun 1, 220 Hafnarfjördur, Republic of Iceland · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-0...

▸ When was this alert issued?

This alert was issued on September 8, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.